Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
Your query has been expanded to `autoimmune disease lupus` |u:www.enterprize.cam.ac.uk.  Search for `autoimmune disease lupus` |u:www.enterprise.cam.ac.uk instead.
1 - 11 of 11 search results for `autoimmune disease lupus` |u:www.enterprise.cam.ac.uk or `autoimmune disease lupus` |u:www.enterprize.cam.ac.uk

  1. Fully-matching results

  2. ken smith Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/ken-smith/feed/
    26 Jun 2024: pThe company’s existing worldwide license covers technology—including algorithms and software—relating to the prediction of disease outcome in relapsing-remitting autoimmune and inflammatory disease, specifically inflammatory bowel disease (IBD

  3. systemic lupus erythematosus Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/systemic-lupus-erythematosus/feed/
    26 Jun 2024: innovation capital inflammatory bowel disease ken smith parkwalk Predictimmune PredictSURE IBD systemic lupus erythematosus https://camenterprise.dev.twkmedia.com/?post_type=news&p=13108 pCambridge Enterprise portfolio company PredictImmune,

  4. BGF Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/bgf/feed/
    26 Jun 2024: Life Sciences Spin-outs Technology Transfer BGF Cambridge innovation capital inflammatory bowel disease ken smith parkwalk Predictimmune PredictSURE IBD systemic lupus erythematosus ... It also allows the organisation to expand its horizons in terms of

  5. PredictSURE IBD Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/predictsure-ibd/feed/
    26 Jun 2024: The US patent is part of PredictImmune’s third family of intellectual property (IP) relating to methods for predicting autoimmune disease risk. ... However, the implication for patients with autoimmune disease is more positive – their exhausted CD8

  6. Department of Medicine Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/department-of-medicine/feed/
    26 Jun 2024: remitting autoimmune and inflammatory disease, specifically inflammatory bowel disease (IBD), both Crohn’s and Ulcerative Colitis. ... of Medicine at the University of Cambridge is further translated into benefits for patients with these additional

  7. parkwalk Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/parkwalk/feed/
    26 Jun 2024: capital inflammatory bowel disease ken smith parkwalk Predictimmune PredictSURE IBD systemic lupus erythematosus https://camenterprise.dev.twkmedia.com/?post_type=news&p=13108 pCambridge Enterprise portfolio company PredictImmune, developers of

  8. inflammatory bowel disease Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/inflammatory-bowel-disease/feed/
    26 Jun 2024: The US patent is part of PredictImmune’s third family of intellectual property (IP) relating to methods for predicting autoimmune disease risk. ... However, the implication for patients with autoimmune disease is more positive – their exhausted CD8

  9. Predictimmune Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/predictimmune/feed/
    26 Jun 2024: of Medicine at the University of Cambridge is further translated into benefits for patients with these additional chronic, debilitating diseases./p pSLE is a form of the autoimmune disease lupus, in ... The US patent is part of PredictImmune’s third

  10. SLE Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/sle/feed/
    26 Jun 2024: pThe company’s existing worldwide license covers technology—including algorithms and software—relating to the prediction of disease outcome in relapsing-remitting autoimmune and inflammatory disease, specifically inflammatory bowel disease (IBD

  11. Paul Kinnon Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/paul-kinnon/feed/
    26 Jun 2024: pThe company’s existing worldwide license covers technology—including algorithms and software—relating to the prediction of disease outcome in relapsing-remitting autoimmune and inflammatory disease, specifically inflammatory bowel disease (IBD

  12. Cambridge innovation capital Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/cambridge-innovation-capital/feed/
    26 Jun 2024: Tue, 30 Jul 2019 08:00:11 0000 Life Sciences Spin-outs Technology Transfer BGF Cambridge innovation capital inflammatory bowel disease ken smith parkwalk Predictimmune PredictSURE IBD systemic lupus erythematosus ... It also allows the organisation to

Refine your results

clear all

Date

Related searches for `autoimmune disease lupus` |u:www.enterprise.cam.ac.uk

By topic

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.